ArticleBMJ open2019

Combination of pembrolizumab and BCG treatment after endoscopic ablation of high-risk superficial upper urinary tract urothelial carcinoma in patients not candidates for radical nephroureterectomy: protocol for phase-II study.

Marcus L Jamil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.